๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers Clinical trials Liupanshui
Clinical trial register · China

Clinical Trials in Liupanshui, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Shanghai 66 Beijing 11 Liupanshui 6 Fuzhou 5 Guangzhou 5
Narrow the registerReset
Recruitment status
Phase
Site location
Shanghai66 Beijing11 Liupanshui6 Fuzhou5 Guangzhou5
All 46 locations
Target enrolment
to

Trials with a site in Liupanshui

6 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Asymptomatic TB With Innovative Modified Short-course Regimens
NCT06153069Tuberculosis
Huashan Hospital
Phase 4
426
Beijing, Liupanshui, Nayong, Shanghai, Hangzhou
2025-11-21
Active, closed
Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis๏ผšBDLL Chinese Cohort
NCT06649721Drug-resistant Tuberculosis, Pulmonary Tuberculosis, Rifampin-resistant Tuberculosis
Huashan Hospital
Phase 3
120
Hefei, Beijing, Xiamen, Nanning, Liupanshui, Shijiazhuang, Harbin, Jiamusi
2024-11-27
Recruiting
A Novel Therapy With a 1-Month Ultrashort Regimen to Halt Progression From Latent Infection to Active Tuberculosis Among Close Contacts (The TB-YOUTH Study)
NCT06022146Tuberculosis, Latent Tuberculosis
Huashan Hospital
Phase 3
3,520
Anshun, Bijie, Daozhen Klau and Hmong Autonomous County in Zun'yi, Guiyang, Liupanshui, Qiandongnan Miao and Dong Autonomous Prefecture, Qiandongnan Miao and Dong Autonomous Region, Qiannan
2023-09-01
Recruiting
Active Screening of Latent Tuberculosis Infection in School Contacts of Active Tuberculosis Patients
NCT06033807Tuberculosis, Latent Tuberculosis Infection
Huashan Hospital
Observational
31,440
Zunyi, Bijie, Linping, Liupanshui, Qiandongnan Miao and Dong Autonomous Prefecture, Qingzhen, Dalian
2023-09-01
Recruiting
Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T)
NCT05401071Tuberculosis, Pulmonary
Huashan Hospital
Phase 2/3
2,442
Guiyang, Kaili, Liupanshui, Zunyi, Shanghai, Zhuji
2023-01-13
Recruiting
Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB)
NCT05081401Multidrug Resistant Tuberculosis, Rifampicin Resistant Tuberculosis, Pre-XDR-TB
Huashan Hospital
Phase 3
1,050
Guiyang, Kaili, Liupanshui, Zunyi, Shanghai
2022-05-23
Rows per page Showing 1–6 of 6
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/liupanshui

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 6 of those studies with a site in Liupanshui that also match the filters currently applied.

How many clinical trials are recruiting in Liupanshui?

5 of the 6 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 0 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Liupanshui), 6 studies
PhaseStudiesRecruitingShare
Phase 33250%
Observational1116.7%
Phase 2/31116.7%
Phase 41116.7%

Most active sponsors

Lead sponsors with the most studies (Liupanshui)
Lead sponsorStudiesRecruiting
Huashan Hospital65
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.